Alyssa Gosling

Coordinated and managed clinical trials in compliance with Good Clinical Practice guidelines and FDA regulations. Screened, enrolled, and consented study participants according to protocol inclusion/exclusion criteria.

Coordinated and managed clinical trials, including participant recruitment, screening, and informed consent. Monitored patient safety and ensured regulatory guidelines (IRB, FDA) compliance.

Collected, processed, and submitted human lab specimens for testing. Maintained exam rooms by OSHA Standards of Health and Safety, sanitized exam instruments, and ensured compliance with safety protocols.

Evaluated drug efficacy and toxicity in osteosarcoma cell lines, contributing to preclinical trial data. Assessed cell viability via fluorescent uptake (Cell Titer-Blue Assay).

Activities and societies: Directed Independent Study: Immune responses: Host vs. breast cancer & inhibition of tumor progression

Directed independent study on immune responses, focusing on host vs. breast cancer and inhibition of tumor progression. Conducted research under the guidance of Dr. Vijaya Iragavarapu-Charyulu and Dr. Marc Kantorow.

Activities and societies: Thesis: The Effects of the Cyclin-Dependent Kinase Inhibitor, Flavopiridol, On Cell Growth and Apoptosis in Canine Osteosarcoma in Vivo

Majored in Biology with a concentration in RadioBiology and a minor in Chemistry. Completed a thesis on the effects of the Cyclin-Dependent Kinase Inhibitor, Flavopiridol, on cell growth and apoptosis in canine osteosarcoma in vivo, advised by Dr. Rowan J Milner and Dr. Rose-Mary Stiffin.

Activities and societies: Thesis: The Culture of Human Organoids to Study Racial Disparity In Pancreatic Acinar Ductal Metaplasia

Participated in the Cancer Research Education & Engagement (CaRE2) Health Equity Post-Baccalaureate Program. Completed a thesis on the culture of human organoids to study racial disparity in pancreatic acinar ductal metaplasia, advised by Dr. Thomas D Schmittgen.